154 related articles for article (PubMed ID: 27763825)
1. In Vitro Dose Studies on Chitosan Nanoplexes for microRNA Delivery in Breast Cancer Cells.
Kaban K; Salva E; Akbuga J
Nucleic Acid Ther; 2017 Feb; 27(1):45-55. PubMed ID: 27763825
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the dual-faced effects of miR-141 with chitosan/miR-141 nanoplexes in breast cancer cells.
Kaban K; Salva E; Akbuga J
J Gene Med; 2019 Sep; 21(9):e3116. PubMed ID: 31389101
[TBL] [Abstract][Full Text] [Related]
3. The effects of chitosan/miR-200c nanoplexes on different stages of cancers in breast cancer cell lines.
Kaban K; Salva E; Akbuga J
Eur J Pharm Sci; 2016 Dec; 95():103-110. PubMed ID: 27260087
[No Abstract] [Full Text] [Related]
4. Encapsulated miR-200c and Nkx2.1 in a nuclear/mitochondria transcriptional regulatory network of non-metastatic and metastatic lung cancer cells.
D'Almeida O; Mothar O; Bondzie EA; Lieumo Y; Tagne L; Gupta S; Volkert T; Levine S; Tagne JB
BMC Cancer; 2019 Feb; 19(1):136. PubMed ID: 30744585
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell.
Liu J; Meng T; Yuan M; Wen L; Cheng B; Liu N; Huang X; Hong Y; Yuan H; Hu F
Int J Nanomedicine; 2016; 11():6713-6725. PubMed ID: 28003747
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol and Morpholine Grafted Cationic Amphiphilic Copolymers for miRNA-34a Delivery.
Sharma S; Mazumdar S; Italiya KS; Date T; Mahato RI; Mittal A; Chitkara D
Mol Pharm; 2018 Jun; 15(6):2391-2402. PubMed ID: 29747513
[TBL] [Abstract][Full Text] [Related]
7. Chitosan Stabilized Gold-Folate-Poly(lactide-co-glycolide) Nanoplexes Facilitate Efficient Gene Delivery in Hepatic and Breast Cancer Cells.
Akinyelu J; Singh M
J Nanosci Nanotechnol; 2018 Jul; 18(7):4478-4486. PubMed ID: 29442622
[TBL] [Abstract][Full Text] [Related]
8. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
[TBL] [Abstract][Full Text] [Related]
10. Physicochemical and biological characterization of chitosan-microRNA nanocomplexes for gene delivery to MCF-7 breast cancer cells.
Santos-Carballal B; Aaldering LJ; Ritzefeld M; Pereira S; Sewald N; Moerschbacher BM; Götte M; Goycoolea FM
Sci Rep; 2015 Sep; 5():13567. PubMed ID: 26324407
[TBL] [Abstract][Full Text] [Related]
11. Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma.
Cosco D; Cilurzo F; Maiuolo J; Federico C; Di Martino MT; Cristiano MC; Tassone P; Fresta M; Paolino D
Sci Rep; 2015 Dec; 5():17579. PubMed ID: 26620594
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable Eri silk nanoparticles as a delivery vehicle for bovine lactoferrin against MDA-MB-231 and MCF-7 breast cancer cells.
Roy K; Patel YS; Kanwar RK; Rajkhowa R; Wang X; Kanwar JR
Int J Nanomedicine; 2016; 11():25-44. PubMed ID: 26730188
[TBL] [Abstract][Full Text] [Related]
13. Folate targeted hybrid lipo-polymeric nanoplexes containing docetaxel and miRNA-34a for breast cancer treatment.
Sharma S; Pukale S; Sahel DK; Singh P; Mittal A; Chitkara D
Mater Sci Eng C Mater Biol Appl; 2021 Sep; 128():112305. PubMed ID: 34474856
[TBL] [Abstract][Full Text] [Related]
14. Chitosan polyplex nanoparticle vector for miR-145 expression in MCF-7: Optimization by design of experiment.
Tekie FS; Atyabi F; Soleimani M; Arefian E; Atashi A; Kiani M; Khoshayand MR; Amini M; Dinarvand R
Int J Biol Macromol; 2015 Nov; 81():828-37. PubMed ID: 26365019
[TBL] [Abstract][Full Text] [Related]
15. Endosomolytic and Tumor-Penetrating Mesoporous Silica Nanoparticles for siRNA/miRNA Combination Cancer Therapy.
Wang Y; Xie Y; Kilchrist KV; Li J; Duvall CL; Oupický D
ACS Appl Mater Interfaces; 2020 Jan; 12(4):4308-4322. PubMed ID: 31939276
[TBL] [Abstract][Full Text] [Related]
16. Effect of silibinin-loaded nano-niosomal coated with trimethyl chitosan on miRNAs expression in 2D and 3D models of T47D breast cancer cell line.
Yazdi Rouholamini SE; Moghassemi S; Maharat Z; Hakamivala A; Kashanian S; Omidfar K
Artif Cells Nanomed Biotechnol; 2018 May; 46(3):524-535. PubMed ID: 28509572
[TBL] [Abstract][Full Text] [Related]
17. Differential expression and androgen regulation of microRNAs and metalloprotease 13 in breast cancer cells.
Ahram M; Mustafa E; Zaza R; Abu Hammad S; Alhudhud M; Bawadi R; Zihlif M
Cell Biol Int; 2017 Dec; 41(12):1345-1355. PubMed ID: 28816390
[TBL] [Abstract][Full Text] [Related]
18. miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
[TBL] [Abstract][Full Text] [Related]
19. Glutathione responsive chitosan-thiolated dextran conjugated miR-145 nanoparticles targeted with AS1411 aptamer for cancer treatment.
Tekie FSM; Soleimani M; Zakerian A; Dinarvand M; Amini M; Dinarvand R; Arefian E; Atyabi F
Carbohydr Polym; 2018 Dec; 201():131-140. PubMed ID: 30241804
[TBL] [Abstract][Full Text] [Related]
20. In vitro silencing effect of chitosan nanoplexes containing siRNA expressing vector targeting VEGF in breast cancer cell lines.
Salva E; Akbuğa J
Pharmazie; 2010 Dec; 65(12):896-902. PubMed ID: 21284259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
